Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology, Can J Gastroenterol J Can Gastroenterol. sept, vol.19, 2005. ,
Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey, J Crohns Colitis. sept, vol.1, issue.1, pp.10-20, 2007. ,
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management, J Crohns Colitis. 1 juill, vol.11, issue.7, pp.769-84, 2017. ,
Epidemiology and Natural History Task Force of the International Organization of the Study of Inflammatory Bowel Disease. A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease, Inflamm Bowel Dis. août, vol.19, issue.9, pp.2001-2011, 2013. ,
High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study, Inflamm Bowel Dis. sept, vol.16, issue.9, pp.1550-1556, 2010. ,
Epidemiology and natural history of inflammatory bowel diseases, Gastroenterology. mai, vol.140, issue.6, pp.1785-94, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00631553
Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases, Gut. sept, vol.57, issue.9, pp.1185-91, 2008. ,
An update on the epidemiology of inflammatory bowel disease in Asia, Am J Gastroenterol. déc, vol.103, issue.12, pp.3167-82, 2008. ,
Emigration to western industrialized countries: A risk factor for developing inflammatory bowel disease, J Crohns Colitis. déc, vol.5, issue.6, pp.566-575, 2011. ,
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology. janv, vol.142, issue.1, pp.46-54, 2012. ,
Geographical variability and environmental risk factors in inflammatory bowel disease, Gut. avr, vol.62, issue.4, pp.630-679, 2013. ,
Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut, vol.39, pp.690-697, 1996. ,
Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data, Inflamm Bowel Dis. mars, vol.12, issue.3, pp.218-244, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00466309
Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999), Gut. juin, vol.53, issue.6, pp.843-851, 2004. ,
Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD) ,
URL : https://hal.archives-ouvertes.fr/hal-01701899
, Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. févr, vol.45, issue.2, pp.89-94, 2013.
Familial occurrence of inflammatory bowel disease, N Engl J Med. 10 janv, vol.324, issue.2, pp.84-92, 1991. ,
Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease, Am J Gastroenterol, vol.94, issue.11, pp.3236-3244, 1999. ,
Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis, J Crohns Colitis, vol.8, issue.11, pp.1480-97, 2014. ,
Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011, Am J Gastroenterol. avr, vol.110, issue.4, pp.564-71, 2015. ,
Prevalence of Inflammatory Bowel Disease among Relatives of Patients with Ulcerative Colitis, Scand J Gastroenterol. 1 janv, vol.22, issue.2, pp.214-222, 1987. ,
Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking, Gut. 1 juill, vol.29, issue.7, pp.990-996, 1988. ,
Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study, Scand J Gastroenterol, vol.35, issue.10, pp.1075-81, 2000. ,
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study, Nat Genet. févr, vol.41, issue.2, pp.216-236, 2009. ,
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nat Genet. mars, vol.43, issue.3, pp.246-52, 2011. ,
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease, Gut, vol.67, issue.1, pp.108-127, 2018. ,
Sulphate-reducing bacteria from ulcerative colitis patients induce apoptosis of gastrointestinal epithelial cells. Microb Pathog, vol.112, pp.126-160, 2017. ,
Low counts of Faecalibacterium prausnitzii in colitis microbiota, Inflamm Bowel Dis. août, vol.15, issue.8, pp.1183-1192, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00657435
Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis, Aliment Pharmacol Ther. juill, vol.38, issue.2, pp.151-61, 2013. ,
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis, Gut. août, vol.63, issue.8, pp.1275-83, 2014. ,
Smoking and inflammatory bowel disease: a meta-analysis, Mayo Clin Proc, vol.81, issue.11, pp.1462-71, 2006. ,
Impact of cessation of smoking on the course of ulcerative colitis, Am J Gastroenterol. juill, vol.96, issue.7, pp.2113-2119, 2001. ,
Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies, Am J Gastroenterol. janv, vol.95, issue.1, pp.171-177, 2000. ,
Appendectomy and protection against ulcerative colitis, N Engl J Med. 15 mars, vol.344, issue.11, pp.808-822, 2001. ,
Te Velde AA. The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms, Am J Gastroenterol. févr, vol.111, issue.2, pp.163-172, 2016. ,
Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis, Am J Clin Nutr, vol.80, issue.5, pp.1342-52, 2004. ,
Inflammatory Bowel Diseases: Review of Known Environmental Protective and Risk Factors Involved, Inflamm Bowel Dis, vol.23, issue.9, pp.1499-509, 2017. ,
Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study, Ann Intern Med. 6 mars, vol.156, issue.5, pp.350-359, 2012. ,
The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis, Am J Gastroenterol. sept, vol.103, issue.9, pp.2394-400, 2008. ,
Antibiotic use and inflammatory bowel diseases in childhood, Gut. janv, vol.60, issue.1, pp.49-54, 2011. ,
Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis, Am J Gastroenterol, vol.109, issue.11, pp.1728-1766, 2014. ,
Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific, Gut. juill, vol.64, issue.7, pp.1063-71, 2015. ,
Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. août, vol.13, issue.8, pp.1453-1463, 2015. ,
Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study, Scand J Gastroenterol. déc, vol.45, issue.12, pp.1464-71, 2010. ,
The relationship between urban environment and the inflammatory bowel diseases: a systematic review and metaanalysis, BMC Gastroenterol. 24 mai, vol.12, p.51, 2012. ,
Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease, Gastroenterology. mai, vol.130, issue.6, pp.1588-94, 2006. ,
Increased short-and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis, Gastroenterology. août, vol.137, issue.2, pp.495-501, 2009. ,
Evidence that stress contributes to inflammatory bowel disease: evaluation, synthesis, and future directions, Inflamm Bowel Dis. juin, vol.11, issue.6, pp.600-608, 2005. ,
Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study, Am J Gastroenterol. janv, vol.102, issue.1, pp.122-153, 2007. ,
Job strain and the risk of inflammatory bowel diseases: individual-participant meta-analysis of 95,000 men and women, PloS One, vol.9, issue.2, p.88711, 2014. ,
Extraintestinal manifestations in inflammatory bowel disease, World J Gastroenterol. 14 déc, vol.11, issue.46, pp.7227-7263, 2005. ,
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study, Lancet Lond Engl. 20 févr, vol.375, issue.9715, pp.657-63, 2010. ,
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders, J Crohns Colitis. 1 juin, vol.11, issue.6, pp.649-70, 2017. ,
Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study, Am J Gastroenterol. août, vol.92, issue.8, pp.1275-1284, 1997. ,
European consensus on the histopathology of inflammatory bowel disease, J Crohns Colitis, vol.7, issue.10, pp.827-51, 2013. ,
A prospective study of first attacks of inflammatory bowel disease and infectious colitis, Scand J Gastroenterol. avr, vol.29, issue.4, pp.318-350, 1994. ,
The surgical pathology of ulcerative colitis, Ann R Coll Surg Engl, vol.12, 1954. ,
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study, N Engl J Med. 24 déc, vol.317, issue.26, pp.1625-1634, 1987. ,
CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease, Dig Dis Sci. sept, vol.52, issue.9, pp.2063-2071, 2007. ,
Correlation of Creactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease, Inflamm Bowel Dis. août, vol.11, issue.8, pp.707-719, 2005. ,
Mucosal Healing Is Associated With Improved Longterm Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.14, issue.9, pp.1245-1255, 2016. ,
Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes, Inflamm Bowel Dis. févr, vol.19, issue.2, pp.332-373, 2013. ,
Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes, Inflamm Bowel Dis. déc, vol.15, issue.12, pp.1851-1859, 2009. ,
, Comparing histological activity indexes in UC. Gut. sept, vol.64, issue.9, pp.1412-1420, 2015.
Development and validation of the Nancy histological index for UC, Gut, vol.66, issue.1, pp.43-52, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01668562
Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis, Inflamm Bowel Dis. mai, vol.19, issue.6, pp.1194-201, 2013. ,
Correlation Between Endoscopic and Histological Activity in Ulcerative Colitis Using Validated Indices, J Crohns Colitis, vol.12, issue.10, pp.1151-1158, 2018. ,
Mucosal healing in inflammatory bowel diseases: a systematic review, vol.61, pp.1619-1654, 2012. ,
Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus, Gastroenterology. mai, vol.148, issue.5, pp.1035-1058, 2015. ,
Second European evidencebased consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis, J Crohns Colitis. déc, vol.6, issue.10, pp.965-90, 2012. ,
Algorithmes de prise en charge de la rectocolite hémorragique en 2015 : Consensus National Français, Hépato-Gastro Oncol Dig. 1 janv, vol.23, issue.1, pp.32-42, 2016. ,
Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis, J Clin Gastroenterol. sept, vol.40, issue.8, pp.669-77, 2006. ,
Factors associated with postoperative morbidity, reoperation and readmission rates after laparoscopic total abdominal colectomy for ulcerative colitis, Colorectal Dis Off J Assoc Coloproctology G B Irel. sept, vol.15, issue.9, pp.1123-1132, 2013. ,
European evidence based consensus on surgery for ulcerative colitis, J Crohns Colitis. janv, vol.9, issue.1, pp.4-25, 2015. ,
Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis, Aliment Pharmacol Ther. 15 févr, vol.31, issue.4, pp.486-92, 2010. ,
Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study, Surg Endosc. août, vol.24, issue.8, pp.1866-71, 2010. ,
Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis, Br J Surg. avr, vol.86, issue.4, pp.493-498, 1999. ,
Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis, Gastroenterol Clin Biol. avr, vol.30, issue.4, pp.594-601, 2006. ,
Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study, Ann Surg. déc, vol.256, issue.6, pp.1045-1053, 2012. ,
A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study, Ann Surg. août, vol.258, issue.2, pp.275-82, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00936957
The risk of colorectal cancer in ulcerative colitis: a metaanalysis, Gut. avr, vol.48, issue.4, pp.526-561, 2001. ,
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations, J Crohns Colitis. févr, vol.7, issue.1, pp.1-33, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00742589
Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD, Gut, vol.67, issue.1, pp.70-78, 2018. ,
Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer, Gastroenterology, vol.151, issue.6, pp.1122-1152, 2016. ,
Indigo carmine-assisted highmagnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation, Endoscopy. déc, vol.37, issue.12, pp.1186-92, 2005. ,
Cortisone in ulcerative colitis; final report on a therapeutic trial, Br Med J, vol.2, issue.4947, pp.1041-1049, 1955. ,
Intensive intravenous regimen for severe attacks of ulcerative colitis, Lancet Lond Engl. 1 juin, vol.1, issue.7866, pp.1067-70, 1974. ,
, Gut. déc, vol.4, pp.299-315, 1963.
The pattern and outcome of acute severe colitis, J Crohns Colitis, vol.4, issue.4, pp.431-438, 2010. ,
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up ,
, Aliment Pharmacol Ther. 1 sept, vol.26, issue.5, pp.747-56, 2007.
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis, Inflamm Bowel Dis. mars, vol.10, issue.2, pp.73-81, 2004. ,
Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis, Gastroenterology. mars, vol.134, issue.3, pp.680-687, 2008. ,
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit, Aliment Pharmacol Ther, vol.38, issue.8, pp.935-980, 2013. ,
Cyclosporine in severe ulcerative colitis refractory to steroid therapy, N Engl J Med. 30 juin, vol.330, issue.26, pp.1841-1846, 1994. ,
Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery, Aliment Pharmacol Ther. 15 mai, vol.19, issue.10, pp.1079-87, 2004. ,
Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease, Gut. févr, vol.57, issue.2, pp.205-215, 2008. ,
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients, Am J Gastroenterol. juin, vol.103, issue.6, pp.1443-50, 2008. ,
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease, Antimicrob Agents Chemother. sept, vol.58, issue.9, pp.5054-5063, 2014. ,
Inflammatory bowel disease imaging: Current practice and future directions, World J Gastroenterol. 21 janv, vol.22, issue.3, pp.917-949, 2016. ,
Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis, Inflamm Bowel Dis. avr, vol.22, issue.4, pp.912-920, 2016. ,
Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity, Dig Dis Sci. juill, vol.39, issue.7, pp.1550-1557, 1994. ,
Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis, Aliment Pharmacol Ther. mars, vol.14, issue.3, pp.273-282, 2000. ,
Reliability and initial validation of the ulcerative colitis endoscopic index of severity, Gastroenterology, vol.145, issue.5, pp.987-95, 2013. ,
The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity ,
, J Crohns Colitis. août, vol.9, issue.8, pp.607-623, 2015.
Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis, Gastroenterol Rep. févr, vol.6, issue.1, pp.38-44, 2018. ,
Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis, J Crohns Colitis. mai, vol.9, issue.5, pp.376-81, 2015. ,
High-dose methylprednisolone in the treatment of active ulcerative colitis, J Clin Gastroenterol. févr, vol.12, issue.1, pp.40-41, 1990. ,
Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. janv, vol.5, issue.1, pp.103-113, 2007. ,
Predicting outcome in severe ulcerative colitis, Gut. juin, vol.38, issue.6, pp.905-915, 1996. ,
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis, Gastroenterology. mai, vol.120, issue.6, pp.1323-1332, 2001. ,
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study, Gastroenterology. juin, vol.128, issue.7, pp.1805-1816, 2005. ,
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial, Lancet Gastroenterol Hepatol, vol.1, issue.1, pp.15-24, 2016. ,
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial, Lancet Lond Engl. 1 déc, vol.380, issue.9857, pp.1909-1924, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00742308
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. juin, vol.4, issue.6, pp.760-765, 2006. ,
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus, J Crohns Colitis. mars, vol.6, issue.2, pp.248-58, 2012. ,
Postoperative complications and mortality following colectomy for ulcerative colitis, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.9, issue.11, pp.972-80, 2011. ,
Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: a case-matched study in 88 patients, Surgery. mai, vol.141, issue.5, pp.640-644, 2007. ,
Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy, J Am Coll Surg. sept, vol.197, issue.3, pp.379-85, 2003. ,
Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features, Gastroenterology. juill, vol.79, issue.1, pp.19-25, 1980. ,
Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis, Am J Gastroenterol. mars, vol.103, issue.3, pp.637-679, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00815884
Albumin as a prognostic marker for ulcerative colitis, World J Gastroenterol. 7 déc, vol.23, issue.45, pp.8008-8024, 2017. ,
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis, Aliment Pharmacol Ther. 1 août, vol.26, issue.3, pp.411-420, 2007. ,
CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis, J Clin Gastroenterol, vol.52, issue.6, pp.48-52, 2018. ,
Does CT influence the decision to perform colectomy in patients with severe ulcerative colitis?, J Gastrointest Surg Off J Soc Surg Aliment Tract. mars, vol.13, issue.3, pp.504-511, 2009. ,
Is abdominal CT useful for the management of patients with severe acute colitis complicating inflammatory bowel disease? A study in 54 consecutive patients, Colorectal Dis Off J Assoc Coloproctology G B Irel. avr, vol.19, issue.4, pp.97-102, 2017. ,
Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis, Eur J Gastroenterol Hepatol, vol.10, issue.10, pp.831-836, 1998. ,
Serum albumin: relationship to inflammation and nutrition, Semin Dial. déc, vol.17, issue.6, pp.432-439, 2004. ,
Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms, Clin Pharmacol Ther. avr, vol.91, issue.4, pp.635-681, 2012. ,
, When albuminemia was under 26 g/l its specificity and PPV were 89 % and 86 %. When CRP/albuminemia ratio was higher than 2.5, it had a sensitivity of 59 %, a specificity of 89 %, a PPV of 89 %. Sensitivity, specificity, Results Forty-nine patients who had colectomy were included: 41 had acute severe ulcerative colitis, 6 had treatment-refractory disease and 2 had dysplasia or colorectal cancer. There were 28 patients in DU+ group and 21 patients in DU-group. CRP was significantly higher when patients had DU (98.9
, Conclusion CRP and albuminemia are the most accurate tests to identify DU in UC, especially when CRP is over 100 mg/l. If we could confirm those results in a prospective cohort